Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review

[1]  H. Tilg,et al.  Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. , 2010, Gastroenterology.

[2]  J. West,et al.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010, The Lancet.

[3]  A. James.  Pregnancy and thrombotic risk , 2010, Critical care medicine.

[4]  M. Picco.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010 .

[5]  G. Nguyen,et al.  Impact of cirrhosis and liver transplant on maternal health during labor and delivery. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  G. Nguyen,et al.  Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  Justina J. Sam,et al.  Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[8]  Clifford W Colwell,et al.  Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition) , 2008 .

[9]  C. Bernstein,et al.  The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  S. Xiao,et al.  Meta‐analysis: the utility and safety of heparin in the treatment of active ulcerative colitis , 2007, Alimentary pharmacology & therapeutics.

[11]  H. Krum,et al.  Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[12]  C. Huerta,et al.  Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.

[13]  A. Taher,et al.  Thalidomide and thrombosis , 2007, Thrombosis and Haemostasis.

[14]  S. Danese,et al.  Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.

[15]  H. Redmond,et al.  The incidence of postoperative venous thrombosis among patients with ulcerative colitis , 2005, Irish journal of medical science.

[16]  W. Reinisch,et al.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? , 2004, Gut.

[17]  W. Bilker,et al.  Seasonal variation in flares of inflammatory bowel disease. , 2004, Gastroenterology.

[18]  W. Sandborn,et al.  Venous Thromboembolism in Inflammatory Bowel Disease , 2004, American Journal of Gastroenterology.

[19]  R. Beart,et al.  Sequential Compression Devices as Prophylaxis for Venous Thromboembolism in High-Risk Colorectal Surgery Patients: Reconsidering American Society of Colorectal Surgeons Parameters , 2003, The American surgeon.

[20]  F. Rodeghiero,et al.  Thalidomide and Thrombosis , 2003, Pathophysiology of Haemostasis and Thrombosis.

[21]  C. Kearon,et al.  Natural History of Venous Thromboembolism , 2003, Circulation.

[22]  J. Heit,et al.  Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.

[23]  W. Bilker,et al.  Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease , 2002, Pharmacoepidemiology and drug safety.

[24]  B. Eriksson,et al.  Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. , 2001, The New England journal of medicine.

[25]  C. Bernstein,et al.  The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study , 2001, Thrombosis and Haemostasis.

[26]  G M Leydon,et al.  Validation of the diagnosis of venous thromboembolism in general practice database studies. , 2000, British journal of clinical pharmacology.

[27]  W M O'Fallon,et al.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.

[28]  A Wajda,et al.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.

[29]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[30]  P. Walker,et al.  A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Anderson FA, Wheeler HB, Goldberg RJ, et al. Arch Intern Med 1991;151:933-8 , 1992 .

[31]  D. Hosmer,et al.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.

[32]  R. Beart,et al.  Vascular complications of inflammatory bowel disease. , 1986, Mayo Clinic proceedings.

[33]  R. Matheny,et al.  100 patient-years of ambulatory home total parenteral nutrition. , 1984, Annals of surgery.

[34]  J. Keller,et al.  Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.